Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2022
7 years of board service in total across 3 boards, counting each seat separately. Longest: bioAffinity Technologies Inc., 4 years.
bioAffinity Technologies Inc.
Director
Velos Acquisition I Corp.
Director · Executive Chairman of BOD
M3-Brigade Acquisition VI Corp.
Director · Executive Chairman of the BOD
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
bioAffinity Technologies Inc. June 7, 202399.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +11,867 | $1.58 | $18,750 |
| Jul 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +10,245 | $1.83 | $18,748 |
| Apr 15, 2023 | bioAffinity Technologies Inc. | Grant or award | +9,920 | $1.89 | $18,749 |
| Jan 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +8,227 | $2.28 | $18,758 |
| Sep 6, 2022 | bioAffinity Technologies Inc. | Derivative conversion | +40,907 | $3.67 | $150,129 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.